1 October 2025 v2026.41.1 micro_entity_frs_105_v1_1_3 filingSoftwarefalsetruetruetruefalseNo description of principal activitytruexbrli:purexbrli:sharesiso4217:GBP143342952025-10-012026-09-30143342952026-09-30143342952025-09-3014334295core:WithinOneYear2026-09-3014334295core:WithinOneYear2025-09-3014334295core:AfterOneYear2025-09-3014334295bus:RegisteredOffice2025-10-012026-09-30143342952024-10-012025-09-3014334295bus:Director12025-10-012026-09-301433429512025-10-012026-09-3014334295countries:EnglandWales2025-10-012026-09-3014334295bus:AuditExemptWithAccountantsReport2025-10-012026-09-3014334295bus:PrivateLimitedCompanyLtd2025-10-012026-09-3014334295bus:Micro-entities2025-10-012026-09-3014334295bus:FullAccounts2025-10-012026-09-30
Company registration number:
14334295
SURGIGOGY LTD
Unaudited Filleted Financial Statements for the period ended
30 September 2026
SURGIGOGY LTD
Statement of Financial Position
30 September 2026
30 Sep 202630 Sep 2025
££
Called up share capital not paid
100
 
100
 
   
Fixed assets
559
 
838
 
   
Current assets
10,166
 
15,359
 
Creditors: amounts falling due within one year
(1,388
 )
(3,417
 )
Net current assets
8,878
 
12,042
 
Total assets less current liabilities
9,437
 
12,880
 
Creditors: amounts falling due after more than one year -  
(4,718
 )
Net assets
9,437
 
8,162
 
   
Capital and reserves
9,437
 
8,162
 

Notes to the Financial Statements

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
Apartment 167 Skyline 165 Granville Street
,
Birmingham
,
West Midlands
,
B1 1JX
, United Kingdom.

2 Average number of employees

The average number of persons employed by the company during the period was
1
(2025:
1.00
).

3 Advances to Directors

During the year, withdrawals and other debits totalling £8,586 were recorded against the director's loan account. The account became overdrawn, reaching a maximum balance of £3,788. The advances were interest-free, with no fixed repayment terms, and were fully settled through credits and dividends declared during the year. At 30 September 2026, the company owed the director £34.
For the period ending
30 September 2026
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
30 October 2026
, and are signed on behalf of the board by:
Peter Rainger
Director
Company registration number:
14334295